TY  - JOUR 
AU  - Abdo, M.
AU  - Belloum, Y.
AU  - Heigener, D.
AU  - Welker, L.
AU  - von Weihe, S.
AU  - Schmidt, M.
AU  - Heuer-Olewinski, N.
AU  - Watermann, I.
AU  - Szewczyk, M.
AU  - Kropidlowski, J.
AU  - Pereira Veiga, Thais
AU  - Elmas, H.
AU  - Perner, S.
AU  - Steurer, S.
AU  - Wikman, H.
AU  - Pantel, K.
AU  - Reck, M.
PY  - 2023
SN  - 1878-0261
UR  - http://hdl.handle.net/20.500.11940/21247
AB  - Alternative sources of tumour information need to be explored in patients with non-small cell lung cancer (NSCLC). Here, we compared programmed cell death ligand 1 (PD-L1) expression on cytology imprints and circulating tumour cells (CTCs) with PD-L1...
LA  - eng
KW  - Humans
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Lung Neoplasms
KW  - B7-H1 Antigen
KW  - Neoplastic Cells, Circulating
KW  - Immunohistochemistry
KW  - Biomarkers, Tumor
TI  - Comparative evaluation of PD-L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non-small cell lung cancer patients
DO  - 10.1002/1878-0261.13415
T2  - Molecular Oncology
M2  - 737
KW  - AS Santiago
KW  - IDIS
VL  - 17
ER  -